Genpact (G)
(Delayed Data from NYSE)
$38.68 USD
+0.20 (0.52%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $38.68 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$38.68 USD
+0.20 (0.52%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $38.68 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Zacks News
Here Are the Reasons Why You Should Pick Genpact Stock Now
by Zacks Equity Research
G's shares benefit from its ability to leverage AI to transform businesses by implementing AI-first end-to-end business processes in production environments.
Here's Why Genpact (G) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
G or EXLS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
G vs. EXLS: Which Stock Is the Better Value Option?
Accenture Launches Personalized Experiences on Salesforce
by Zacks Equity Research
The move is part of ACN's growth strategy that focuses on delivering 360?? value to its stakeholders.
Accenture Ventures Adds EMTECH to its Investment Portfolio
by Zacks Equity Research
The investment seems integral to ACN's broader growth strategy, which emphasizes delivering comprehensive value through technology.
Accenture and Unilever Collaborate on Generative AI Platform
by Zacks Equity Research
ACN's collaboration with UL marks a strategic move toward strengthening its position as a leader in digital transformation.
Are Investors Undervaluing Genpact (G) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
VoLT Strategy Drives Booz Allen's Success Amid Rising Expenses
by Zacks Equity Research
BAH leverages its VoLT strategy to improve market position, scale businesses and grow its technology and solutions.
Is Limbach (LMB) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Limbach (LMB) and Genpact (G) have performed compared to their sector so far this year.
Envestnet Stock Appreciates 27% Year to Date: Here's What to Know
by Zacks Equity Research
ENV's business model ensures solid asset- and subscription-based recurring revenue-generation capacity.
Why Genpact (G) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Add FactSet Stock in Your Portfolio Now
by Zacks Equity Research
FDS has a consistent track record of rewarding its shareholders through share repurchases and dividends.
Here's Why You Should Retain Broadridge Financial Stock Now
by Zacks Equity Research
BR is executing well on its growth strategy in governance, capital markets and wealth management.
Zacks.com featured highlights Genpact, MPLX, Exelixis, Paramount Global and H&R Block
by Zacks Equity Research
Genpact, MPLX, Exelixis, Paramount Global and H&R Block have been highlighted in this Screen of The Week article.
G vs. EXLS: Which Stock Is the Better Value Option?
by Zacks Equity Research
G vs. EXLS: Which Stock Is the Better Value Option?
5 Top-Ranked Value Stocks With Discounted PEG Ratio to Buy
by Urmimala Biswas
Five PEG-based stocks that fulfill our screening criteria are Genpact, MPLX, Exelixis, Paramount Global and H&R Block.
Why You Should Retain Corpay Stock in Your Portfolio Now
by Zacks Equity Research
CPAY has been consistently pursuing acquisitions and investments to increase its customer base, workforce and operational capabilities.
Genpact (G) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Reasons Why You Should Hold Rollins (ROL) Stock Now
by Zacks Equity Research
Rollins (ROL) has a track record of consistent dividend payments.
Here's Why H&R Block (HRB) Stock is a Great Pick Right Now
by Zacks Equity Research
The main drivers of H&R Block's (HRB) post-pandemic performance are digital enablement of business, client addition and retention, and greater usage of AI.
Reasons Why You Should Bet on Charles River (CRAI) Stock Now
by Zacks Equity Research
Commitment to shareholder returns makes Charles River (CRAI) a reliable way for investors to compound wealth over the long term.
CEB Acquisition Benefits Gartner (IT) Amid Tough Competition
by Zacks Equity Research
Gartner (IT) is gaining from its ability to provide insights using data collected by advanced technologies.
Is First Trust Industrials/Producer Durables AlphaDEX ETF (FXR) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXR
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Cellebrite DI Ltd. (CLBT) and Genpact (G) have performed compared to their sector so far this year.
Is Genpact (G) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.